What you need to know to understand air quality warnings in Canada
What are the possible health impacts?
Article content
The immediate health impacts of poor air quality can include difficulty breathing, eye and throat irritation, cough, wheezing and chest tightness, and it can worsen any pre-existing symptoms of respiratory conditions, such as asthma.
Article content
When it comes to long-term impacts, there's still research to be done on the impact of exposure to wildfire smoke. However, preliminary results show 'an impact on lung function, a slight increased risk of lung cancer, brain tumours, potential increased risk of Alzheimer's disease and dementia, and a potential effect on childhood development and developmental disorders of childhood,' said Green.
Article content
'Wildfire smoke likely has negative health impacts on all body systems and we should avoid repeated and long term exposure,' said Green.
Article content
On July 14, until 11 a.m., Toronto had an AQHI of 10, meaning it was better to stay indoors, while in Halifax, the AQHI was 2, an ideal air quality for outdoor activities.
Article content
Article content
The poor air quality in many parts of the country, like Ontario, Manitoba and Saskatchewan, was caused mainly by the forest fires over Northern Ontario and the Prairies.
Article content
'An N95 mask will filter out a large portion of the particulate matter. It's not going to filter out those other air pollutants, like nitrogen dioxide and ozone and it's not a long term solution,' Green said. However, a surgical mask won't help, only an N95 worn correctly.
Article content
'If someone must be outside and the AQHI is high, I would say, sure, yes, it will protect you if you wear an N95 mask,' said Green.
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
4 hours ago
- Cision Canada
Stay Home Forever Inc. Appoints Dane Clarke as First President and Chief Operating Officer
Industry leader brings culture-driven approach to Ontario-based homecare provider Stay Home Forever Inc. as he steps into the newly created role of President and Chief Operating Officer. TORONTO, July 29, 2025 /CNW/ - Stay Home Forever Inc. ("SHF"), a leading provider of private homecare services across Ontario, today announced the appointment of Dane Clarke as the President and Chief Operating Officer, effective immediately. To support its next phase of growth, SHF has created this new role, appointing Dane to lead operations and strategy while driving immediate impact with a culture-driven mission. Dane brings over 20 years of executive experience in healthcare operations, workforce strategy, and organizational growth. He has held leadership roles at CBI Health Group, Sinai Health Systems, and WSIB, leading initiatives that improved outcomes and expanded service delivery. Dane also played a key role in driving system-level change and navigating crisis response for healthcare organizations, including Ontario Health Teams (OHTs), co-chairing the Home Care Table during the covid-19 pandemic, and a key contributor to various initiatives and stakeholder engagements with Ontario Health. He attended the Ivey School of Business, reinforcing his ability to lead transformational change and cross-sector healthcare initiatives. "We are thrilled to welcome Dane to the SHF family," said Saye Sathiyakumar, CEO of Stay Home Forever Inc. "His proven leadership, deep industry knowledge, and passion for compassionate care align perfectly with our values. Dane's vision and operational expertise will be instrumental as we continue to scale our services and innovate in the homecare sector." "Joining Stay Home Forever is both a professional and personal calling," said Dane. "I look forward to working closely with Saye and the SHF team to strengthen our foundation, expand our services, and meet the growing need for culturally responsive care in Ontario." Dane's appointment reflects Stay Home Forever's identity as a proudly minority-owned company. As a second-generation Canadian, his personal experiences bring critical insight to a sector where much of the workforce shares similar backgrounds. His leadership helps ensure that the voices of underrepresented communities are reflected at every level of care. Stay Home Forever Inc. has earned a reputation for delivering personalized and client-centred care rooted in the belief that everyone deserves to live with dignity, comfort and connection. With Dane's leadership, SHF will continue to expand its tailored services and advance culturally responsive care for families across Ontario. About Stay Home Forever Inc. Founded in 2019, Stay Home Forever Inc. is a leading provider of private homecare services in Ontario. The company offers a comprehensive range of services - including personal care, companionship, nursing, and specialized support - all designed to promote independence and enhance quality of life. SHF is committed to delivering compassionate, reliable, and culturally appropriate care that meets the highest standards of excellence.
National Post
5 hours ago
- National Post
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
Article content Phase 3 data show Bausch + Lomb's LUMIFY Preservative Free eye drops are as safe and effective as the original LUMIFY in reducing ocular redness The multicenter study with 380 participants confirmed that LUMIFY Preservative Free eye drops are non-inferior in efficacy to the original LUMIFY and have a favorable safety profile, offering an effective preservative-free option for sensitive eyes LUMIFY delivers noticeable results in one minute, lasts up to eight hours and is the No. 1 doctor-recommended redness reliever brand; more info at Article content VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Ophthalmology and Therapy has published results from a phase 3 study which assessed the efficacy and safety of LUMIFY Preservative Free redness reliever eye drops compared to LUMIFY redness reliever eye drops for reducing ocular redness. Article content 'Since launching in 2018, LUMIFY has been the No. 1 doctor-recommended redness reliever brand, known for delivering noticeable results in one minute and lasting up to eight hours,' 1 said John Ferris, president, Consumer, Bausch + Lomb. 'This study demonstrates that our new LUMIFY Preservative Free eye drops reduce redness quickly and are just as safe and effective as the original LUMIFY, providing a needed option for patients with eye sensitivities.' Article content In the randomized, active-controlled, multicenter study, 380 participants with ocular redness received either LUMIFY Preservative Free or LUMIFY, administered as a single drop four times daily for four weeks. The primary objective was to demonstrate that LUMIFY Preservative Free is non-inferior to LUMIFY in reducing ocular redness. The primary efficacy endpoint was investigator-assessed ocular redness score at eight timepoints from five-minutes to 240-minutes after drop administration on day one. The secondary objective of the study was to compare the safety of LUMIFY Preservative Free and LUMIFY. Article content The study met its primary objective, confirming that LUMIFY Preservative Free is statistically non-inferior to LUMIFY in reducing ocular redness in adults. A day one analysis of all 11 time points (one minute to 480 minutes post-administration) further supported these findings; and additional secondary efficacy endpoint data from one minute, 360 minutes and 480 minutes post-administration demonstrated that LUMIFY Preservative Free performs similarly to LUMIFY. The overall safety profile of LUMIFY Preservative Free was favorable and comparable to LUMIFY, and the occurrence of ocular treatment-emergent adverse events was similar in both treatment groups. In this clinical trial, LUMIFY Preservative Free demonstrated to have a low incidence of side effects, like rebound redness and loss of efficacy over time, when used as directed. Article content 'The results show that LUMIFY Preservative Free is a well-tolerated alternative option for consumers with ocular redness who have sensitivities to preservatives or are at increased risk of ocular surface disease,' said Melissa Toyos, MD, and partner, Toyos Clinic, Nashville, TN. Article content About the LUMIFY Brand Article content The LUMIFY brand began in 2018 with the U.S. launch of LUMIFY redness reliever eye drops. Before LUMIFY, redness relievers relied on the same ingredients for decades and were associated with well-known side effects. LUMIFY and LUMIFY Preservative Free are the only over-the-counter redness relievers formulated with low-dose brimonidine tartrate 0.025% that selectively target eye redness and offer excellent results with a lower risk of rebound redness and loss of efficacy when used as directed. In 2023, Bausch + Lomb introduced LUMIFY EYE ILLUMINATIONS™, a line of specialty eye care products specifically developed for the sensitive area around the eyes. In June 2025, Bausch + Lomb launched LUMIFY Preservative Free eye drops in the U.S. For more information on the LUMIFY brand, visit Article content Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit Article content Facebook Article content , Article content Instagram Article content , Article content LinkedIn Article content , Article content X Article content and Article content YouTube Article content . Article content References Article content ©2025 Bausch + Lomb. Article content Article content Article content Article content Article content Article content Contacts Article content Media Contact: Article content Article content Kristy Marks Article content Article content Article content
CTV News
5 hours ago
- CTV News
Happy days for fundraising campaign in New Tecumseth
Alliston and Angus McDonald's McHappy Day raised $12,500 for the Stevenson Memorial Hospital Foundation (SMHF). In addition, SMHF received an extra $14,000 during its Because of YOU relaunch event, further strengthening its partnership and commitment to hospital redevelopment efforts. Together, this funding brings the total contributions from MacKinnon Restaurants, that owns McDonald's in both Alliston and Angus, to an impressive $200,000 to the Stevenson Memorial Hospital Foundation. 'We're incredibly proud to be part of a community that values and supports our local hospital. Every dollar raised during events like McHappy Day makes a real difference—it helps us provide the best possible care for our family, neighbours, and loved ones,' said Rory MacKinnon, owner/operator of McDonald's in Alliston and Angus. The Because of You campaign is an effort to raise funds from the community to help build a future of Stevenson Memorial Hospital. This project will triple the size of the hospital, provide expanded emergency care and advanced diagnostic imaging, including Stevenson's first MRI suite. Community funds will also be put toward modern inpatient facilities, and specialized surgical services, all designed to meet the evolving healthcare needs of the growing community. 'We are deeply grateful to McDonald's in Alliston and Angus for their incredible generosity and unwavering support during McHappy Day. 'Their contributions play a crucial role in our overall efforts to advance the construction of Stevenson's new facility, which will significantly enhance healthcare services for our community,' said Frank Cerisano, CEO for SMHF. 'This support is significant as it helps us progress towards our $80 million Because of YOU campaign goal, helping to ensure that every patient continues to receive the quality care they deserve today and for generations to come.'
